<DOC>
	<DOCNO>NCT02600104</DOCNO>
	<brief_summary>Prospective clinical study , Up 100 healthy adult volunteer seek Treatment Wrinkles Reduction facial area , male females 18 75 year age , 5 investigational site .</brief_summary>
	<brief_title>Evaluate Performance PicoWayTM Picosecond Fractional Laser Wrinkles Reduction</brief_title>
	<detailed_description>This open-label , multi-center study . Subjects study receive four ( 4 ) facial treatment 3-8 week interval , PicoWayTM device-fractional hand piece 1064nm and/or 532nm accord study protocol . Subjects follow phone 7 day post first treatment study staff , return follow‐up ( FU ) visit clinic : 6 week 12 week follow last treatment . Methodology describe protocol evaluate efficacy safety treatment carry visit clinic .</detailed_description>
	<criteria>1 . Healthy female male subject 18 75 year age 2 . Has Fitzpatrick skin type IVI 3 . Subjects seek treatment wrinkle reduction willing undergo laser treatment improvement 4 . Have mild moderate bilateral perioral and/or periorbital wrinkle 5 . Willing receive propose PicoWayTM fractional treatment comply study ( protocol ) requirement 6 . Willing photograph image take treated area use evaluation , publication presentation ( subject identity mask ) 7 . For female subject : pregnant lactate either postmenopausal , surgically sterilize , use medically acceptable form birth control least 3 month prior enrollment ( i.e. , oral contraceptive , contraceptive implant , barrier method spermicide abstinence ) 8 . Informed consent process complete subject consent sign 1 . Pregnant plan become pregnant , give birth le 3 month ago , and/or breast feeding 2 . Hypersensitivity light exposure 3 . Active sun tan facial area 4 . Suffering significant skin condition treat area inflammatory skin condition , include , limited , open laceration abrasion , hidradenitis , dermatitis treatment area prior treatment ( duration resolution per Investigator 's discretion ) treatment course 5 . Is take medication ( ) sunlight contraindication 6 . Has history squamous cell carcinoma melanoma 7 . History keloid scarring , abnormal wound heal / prone bruise 8 . History epidermal dermal disorder ( particularly involve collagen microvascularity ) , include collagen vascular disease vasculitic disorder 9 . Has use oral isotretinoin ( Accutane® ) within 12 month initial treatment plan use course study . Note : Skin must regain normal degree moisture prior treatment , e.g. , lack noticeable skin flaking , skin peel skin surface roughness . 10 . A laser procedure , peel use lighten cream perform area treat past six month 11 . History immunosuppression/immune deficiency disorder ( include HIV infection AIDS ) currently use immunosuppressive medication 12 . Known allergy lidocaine , tetracaine , Xylocaine epinephrine 13 . Subjects pigment lesion consider acceptable study investigator condition , investigator 's opinion , would make unsafe treat . 14 . As per investigator 's discretion , physical mental condition might make unsafe subject participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>